Skip to main content

Table 7 Association between Sponsor and clinical outcomes: Growth

From: Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: A Systematic Review

  

Assessment of outcome

  

Growth

Source of funding

Positive*

Neutral*

Chi-square p value

Fisher’s exact p value

  

n (%)$$

n (%)$$

  

Weight gain N = 56

Industry

2 (3.6)

35 (62.5)

0.309

0.266

 

None/Not clear

2 (3.6)

10 (17.9)

  
 

Non industry

0

7 (12.5)

  

Length gain N = 40

Industry

3 (7.5)

29 (72.5)

0.667

1.00

 

None/Not clear

 

6 (15)

  
 

Non industry

 

2 (5)

  

Head Circumference N = 31

Industry

4 (12.9)

23 (74.2)

0.712

1.00

 

None /Not clear

 

3 (9.7)

  
 

Non industry

 

1 (3.2)

  
  1. $$Overall percentage.
  2. *Positive: synbiotic, probiotic or prebiotic supplementation had a statistically significant effect, p < 0.05. There were significant differences between study groups (in favour of experimental group).
  3. *Neutral: synbiotic, probiotic or prebiotic supplementation did not have a statistically significant effect, p > 0.05, No significant differences between study groups.
Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us